81 related articles for article (PubMed ID: 37292754)
1. A DNA Unwinding Equilibrium Serves as a Checkpoint for CRISPR-Cas12a Target Discrimination.
Singh J; Liu KG; Allen A; Jiang W; Qin PZ
bioRxiv; 2023 May; ():. PubMed ID: 37292754
[TBL] [Abstract][Full Text] [Related]
2. A DNA unwinding equilibrium serves as a checkpoint for CRISPR-Cas12a target discrimination.
Singh J; Liu KG; Allen A; Jiang W; Qin PZ
Nucleic Acids Res; 2023 Sep; 51(16):8730-8743. PubMed ID: 37522352
[TBL] [Abstract][Full Text] [Related]
3. Site-Specific Labeling Reveals Cas9 Induces Partial Unwinding Without RNA/DNA Pairing in Sequences Distal to the PAM.
Li Y; Liu Y; Singh J; Tangprasertchai NS; Trivedi R; Fang Y; Qin PZ
CRISPR J; 2022 Apr; 5(2):341-352. PubMed ID: 35352981
[TBL] [Abstract][Full Text] [Related]
4. CRISPR-Cas9 Activities with Truncated 16-Nucleotide RNA Guides Are Tuned by Target Duplex Stability Beyond the RNA/DNA Hybrid.
Li Y; Cooper BH; Liu Y; Wu D; Zhang X; Rohs R; Qin PZ
Biochemistry; 2023 Sep; 62(17):2541-2548. PubMed ID: 37552860
[TBL] [Abstract][Full Text] [Related]
5. CRISPR-Cas effector specificity and cleavage site determine phage escape outcomes.
Schelling MA; Nguyen GT; Sashital DG
PLoS Biol; 2023 Apr; 21(4):e3002065. PubMed ID: 37058530
[TBL] [Abstract][Full Text] [Related]
6. RNA-Independent DNA Cleavage Activities of Cas9 and Cas12a.
Sundaresan R; Parameshwaran HP; Yogesha SD; Keilbarth MW; Rajan R
Cell Rep; 2017 Dec; 21(13):3728-3739. PubMed ID: 29281823
[TBL] [Abstract][Full Text] [Related]
7. CRISPR-Cas12a Nucleases Bind Flexible DNA Duplexes without RNA/DNA Complementarity.
Jiang W; Singh J; Allen A; Li Y; Kathiresan V; Qureshi O; Tangprasertchai N; Zhang X; Parameshwaran HP; Rajan R; Qin PZ
ACS Omega; 2019 Oct; 4(17):17140-17147. PubMed ID: 31656887
[TBL] [Abstract][Full Text] [Related]
8. Spontaneous Embedding of DNA Mismatches Within the RNA:DNA Hybrid of CRISPR-Cas9.
Mitchell BP; Hsu RV; Medrano MA; Zewde NT; Narkhede YB; Palermo G
Front Mol Biosci; 2020; 7():39. PubMed ID: 32258048
[TBL] [Abstract][Full Text] [Related]
9. PAM-Engineered Toehold Switches as Input-Responsive Activators of CRISPR-Cas12a for Sensing Applications.
Bagheri N; Chamorro A; Idili A; Porchetta A
Angew Chem Int Ed Engl; 2024 Apr; 63(17):e202319677. PubMed ID: 38284432
[TBL] [Abstract][Full Text] [Related]
10. 2'-
Ke Y; Ghalandari B; Huang S; Li S; Huang C; Zhi X; Cui D; Ding X
Chem Sci; 2022 Feb; 13(7):2050-2061. PubMed ID: 35308857
[TBL] [Abstract][Full Text] [Related]
11. Development of an in vivo cleavable donor plasmid for targeted transgene integration by CRISPR-Cas9 and CRISPR-Cas12a.
Ishibashi R; Maki R; Kitano S; Miyachi H; Toyoshima F
Sci Rep; 2022 Oct; 12(1):17775. PubMed ID: 36272994
[TBL] [Abstract][Full Text] [Related]
12. Structure- and Content-Dependent Efficiency of Cas9-Assisted DNA Cleavage in Genome-Editing Systems.
Baranova SV; Zhdanova PV; Lomzov AA; Koval VV; Chernonosov AA
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430368
[TBL] [Abstract][Full Text] [Related]
13. PAM-independent ultra-specific activation of CRISPR-Cas12a via sticky-end dsDNA.
Zhang W; Mu Y; Dong K; Zhang L; Yan B; Hu H; Liao Y; Zhao R; Shu W; Ye Z; Lu Y; Wan C; Sun Q; Li L; Wang H; Xiao X
Nucleic Acids Res; 2022 Dec; 50(22):12674-12688. PubMed ID: 36484104
[TBL] [Abstract][Full Text] [Related]
14. LAMP-CRISPR-Cas12-based diagnostic platform for detection of Mycobacterium tuberculosis complex using real-time fluorescence or lateral flow test.
Wang Y; Li J; Li S; Zhu X; Wang X; Huang J; Yang X; Tai J
Mikrochim Acta; 2021 Sep; 188(10):347. PubMed ID: 34542728
[TBL] [Abstract][Full Text] [Related]
15. Self-Supplying Guide RNA-Mediated CRISPR/Cas12a Fluorescence System for Sensitive Detection of T4 PNKP.
Yuan X; Yuan H; Liu B; Liu Y
Molecules; 2022 Dec; 27(24):. PubMed ID: 36558152
[TBL] [Abstract][Full Text] [Related]
16. CRISPR-Cas nucleases and base editors for plant genome editing.
Gürel F; Zhang Y; Sretenovic S; Qi Y
aBIOTECH; 2020 Jan; 1(1):74-87. PubMed ID: 36305010
[TBL] [Abstract][Full Text] [Related]
17. Deciphering Off-Target Effects in CRISPR-Cas9 through Accelerated Molecular Dynamics.
Ricci CG; Chen JS; Miao Y; Jinek M; Doudna JA; McCammon JA; Palermo G
ACS Cent Sci; 2019 Apr; 5(4):651-662. PubMed ID: 31041385
[TBL] [Abstract][Full Text] [Related]
18. Protospacer adjacent motif (PAM)-distal sequences engage CRISPR Cas9 DNA target cleavage.
Cencic R; Miura H; Malina A; Robert F; Ethier S; Schmeing TM; Dostie J; Pelletier J
PLoS One; 2014; 9(10):e109213. PubMed ID: 25275497
[TBL] [Abstract][Full Text] [Related]
19. CRISPR/Cas12a Powered DNA Framework-Supported Electrochemical Biosensing Platform for Ultrasensitive Nucleic Acid Analysis.
Su J; Ke Y; Maboyi N; Zhi X; Yan S; Li F; Zhao B; Jia X; Song S; Ding X
Small Methods; 2021 Dec; 5(12):e2100935. PubMed ID: 34928030
[TBL] [Abstract][Full Text] [Related]
20. Cas9 versus Cas12a/Cpf1: Structure-function comparisons and implications for genome editing.
Swarts DC; Jinek M
Wiley Interdiscip Rev RNA; 2018 Sep; 9(5):e1481. PubMed ID: 29790280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]